Ricardo Collado

A plasma metabolomic signature discloses human breast cancer

Mariona Jové, Ricardo Collado, José L. Quiles et al. · Oncotarget · 2017 · 81 citations · Full text

Clinical guideline SEOM: cancer of unknown primary site

Ricardo Collado, Andrés García‐Palomo, Luis de la Cruz‐Merino et al. · Clinical & Translational Oncology · 2014 · 21 citations · Full text

Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non–Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial

Solange Peters, Rolf A. Stahel, Urania Dafni et al. · Journal of Thoracic Oncology · 2016 · 21 citations · Full text

Oncology, Emphasis-lung Trial, Metronomic Therapy +12

A randomized phase II/III study of cabazitaxel versus vinflunine in metastatic or locally advanced transitional cell carcinoma of the urothelium (SECAVIN)

Joaquim Bellmunt, J. Martijn Kerst, Federico Vázquez et al. · Annals of Oncology · 2017 · 20 citations · Full text

Urology, Genitourinary Cancer, Medicine +5

761P Impact of the combination of durvalumab (MEDI4736) plus olaparib (AZD2281) administered prior to surgery in the molecular profile of resectable urothelial bladder cancer. NEODURVARIB trial

Juan Francisco Rodríguez-Moreno, Guillermo de Velasco, Carlos Álvarez-Fernández et al. · Annals of Oncology · 2020 · 17 citations · Full text

Surgical Oncology, Urology, Genitourinary Cancer +9